Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Aug 11, 2025

Accession no.
0001628280-25-039397
Filed
Aug 11, 2025
Trade date
Jul 1-31, 2025
Filing delay
41 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 22 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.87K. It was filed 41 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2025Common StockPPurchaseAcquired+80$3.56+$284.8286,713Direct
Jul 2, 2025Common StockPPurchaseAcquired+80$3.52+$281.6286,793Direct
Jul 3, 2025Common StockPPurchaseAcquired+80$3.31+$264.8286,873Direct
Jul 7, 2025Common StockPPurchaseAcquired+80$3.23+$258.4286,953Direct
Jul 8, 2025Common StockPPurchaseAcquired+80$3.06+$244.8287,033Direct
Jul 9, 2025Common StockPPurchaseAcquired+80$3.05+$244287,113Direct
Jul 10, 2025Common StockPPurchaseAcquired+80$3.20+$256287,193Direct
Jul 11, 2025Common StockPPurchaseAcquired+80$3.21+$256.8287,273Direct
Jul 14, 2025Common StockPPurchaseAcquired+80$3.46+$276.8287,353Direct
Jul 15, 2025Common StockPPurchaseAcquired+80$3.45+$276287,433Direct
Jul 16, 2025Common StockPPurchaseAcquired+80$3.79+$303.2287,513Direct
Jul 17, 2025Common StockPPurchaseAcquired+80$3.82+$305.6287,593Direct
Jul 18, 2025Common StockPPurchaseAcquired+80$3.59+$287.2287,673Direct
Jul 21, 2025Common StockPPurchaseAcquired+80$3.45+$276287,753Direct
Jul 22, 2025Common StockPPurchaseAcquired+80$3.47+$277.6287,833Direct
Jul 23, 2025Common StockPPurchaseAcquired+80$3.54+$283.2287,913Direct
Jul 24, 2025Common StockPPurchaseAcquired+80$3.55+$284287,993Direct
Jul 25, 2025Common StockPPurchaseAcquired+80$3.37+$269.6288,073Direct
Jul 28, 2025Common StockPPurchaseAcquired+68$3.47+$235.96288,141Direct
Jul 29, 2025Common StockPPurchaseAcquired+68$3.33+$226.44288,209Direct
Jul 30, 2025Common StockPPurchaseAcquired+68$3.55+$241.4288,277Direct
Jul 31, 2025Common StockPPurchaseAcquired+68$3.50+$238288,345Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)